Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5690709 | Gynecologic Oncology | 2016 | 9 Pages |
Abstract
Our findings suggest that miR-760 represents a potential onco-miR and participates in ovarian cancer carcinogenesis, which highlight its potential as a target for ovarian cancer therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Yanbin Liao, Yalan Deng, Jun Liu, Zhanying Ye, Zeshan You, Shuzhong Yao, Shanyang He,